Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Fasciotomy
Khalil, Mahmoud
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
Update on PCSK9 therapies for the treatment of dyslipidemia.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety.
PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety. Rev Cardiovasc Med. 2018; 19(S1):S31-S46.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Anticholesteremic Agents
Biomarkers
Cholesterol, LDL
Dyslipidemias
Humans
Proprotein Convertase 9
Serine Proteinase Inhibitors
Treatment Outcome
authors with profiles
Michael Davidson